Loading organizations...
Loading organizations...
Product preventing contrast-induced nephropathy in at-risk patients.
RenalGuard Solutions has raised $21.5M across 2 funding rounds.
RenalGuard Solutions has raised $21.5M in total across 2 funding rounds.
RenalGuard Solutions has raised $21.5M in total across 2 funding rounds.
RenalGuard Solutions's investors include Abiomed, Alan Adler, Genesis Capital Advisors.
RenalGuard Solutions has raised $21.5M across 2 funding rounds. Most recently, it raised $7.0M Other Equity in September 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 13, 2018 | $7.0M Other Equity | Abiomed | |
| Mar 16, 2017 | $14.5M Series A | Alan Adler | Genesis Capital Advisors |